Advertisement
Advertisement
IGC
IGC Pharma, Inc.
0.27
USDSponsored
0.00
+1.28%
Jun 24, 15:56 UTC -4
Closed
After-Market
0.27
+0.01
+2.09%
IGC Earnings Reports
Positive Surprise Ratio
IGC beat 4 of 6 last estimates.
67%
Next Report
Date of Next Report
Aug 12, 2026
Estimate for Q1 27 (Revenue/ EPS)
$248.46K
/-$0.01
Implied change from Q4 26 (Revenue/ EPS)
--
/--
Implied change from Q1 26 (Revenue/ EPS)
-24.25%
/-50.00%
IGC Pharma, Inc. earnings per share and revenue
On Jun 15, 2026, IGC reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.02 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 199.98 thousand, with a --% difference.
Looking ahead to Q1 27, 2 analysts forecast an EPS of -0.01 USD, with revenue projected to reach 248.46 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were IGC Pharma, Inc.'s earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, IGC Pharma, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to IGC Pharma, Inc.'s Q4 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is IGC Pharma, Inc. expected to report next?
The next earning report is scheduled for Aug 12, 2026.
What are the forecasts for IGC Pharma, Inc.'s next earnings report?
Based on 2
analysts, IGC Pharma, Inc. is expected to report EPS of -$0.01 and revenue of $248.46K for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement